Aratana Therapeutics Inc (NASDAQ:PETX)

4.09
Delayed Data
As of Feb 23
 +0.05 / +1.24%
Today’s Change
3.91
Today|||52-Week Range
7.67
-22.24%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close4.04
Today’s open4.07
Day’s range3.93 - 4.13
Volume257,383
Average volume (3 months)478,204
Market cap$175.9M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+61.22%
Earnings growth (this year)-7.07%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+5,585.99%
P/E ratioNM
Price/Sales6.57
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.01+0.18%
ARDXArdelyx Inc+0.25+4.55%
FBIOFortress Biotech Inc+0.22+5.77%
NLNKNewLink Genetics Cor...+0.10+1.43%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$38.6M
Annual profit (last year)-$33.6M
Net profit margin-87.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts